KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Total Non-Current Liabilities: 2017-2025

Historic Total Non-Current Liabilities for Elanco Animal Health (ELAN) over the last 7 years, with Sep 2025 value amounting to $6.2 billion.

  • Elanco Animal Health's Total Non-Current Liabilities rose 0.36% to $6.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $6.2 billion, marking a year-over-year increase of 0.36%. This contributed to the annual value of $6.0 billion for FY2024, which is 21.83% down from last year.
  • Elanco Animal Health's Total Non-Current Liabilities amounted to $6.2 billion in Q3 2025, which was down 2.12% from $6.3 billion recorded in Q2 2025.
  • Elanco Animal Health's Total Non-Current Liabilities' 5-year high stood at $8.7 billion during Q1 2021, with a 5-year trough of -$183.0 million in Q2 2022.
  • Moreover, its 3-year median value for Total Non-Current Liabilities was $7.4 billion (2024), whereas its average is $7.0 billion.
  • In the last 5 years, Elanco Animal Health's Total Non-Current Liabilities slumped by 102.12% in 2022 and then soared by 4,452.46% in 2023.
  • Over the past 5 years, Elanco Animal Health's Total Non-Current Liabilities (Quarterly) stood at $8.7 billion in 2021, then fell by 8.44% to $8.0 billion in 2022, then decreased by 3.07% to $7.7 billion in 2023, then fell by 21.83% to $6.0 billion in 2024, then grew by 0.36% to $6.2 billion in 2025.
  • Its Total Non-Current Liabilities stands at $6.2 billion for Q3 2025, versus $6.3 billion for Q2 2025 and $6.1 billion for Q1 2025.